GATA3 expression can be seen in a minority of endometrial carcinomas: 6% reported by Pors et al., including endometrioid adenocarcinomas, but these cases were always TTF1 negative [10,20]. This evidence concerns the gene GATA3 and endometrioid adenocarcinoma.